Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Nov 23;21(1):500.
doi: 10.1186/s12882-020-02127-7.

Comparison of physical activity and quality of life in home haemodialysis (HHD) patients versus conventional in-centre haemodialysis (ICHD) patients: the observational, longitudinal, prospective, international, multicentric SeCoIA study protocol

Natalia Target  1 , Cécile Courivaud  2 , Pierre Antoine Michel  3 , Salima Daoud  4 , Michel Thomas  5
Affiliations
Observational Study

Comparison of physical activity and quality of life in home haemodialysis (HHD) patients versus conventional in-centre haemodialysis (ICHD) patients: the observational, longitudinal, prospective, international, multicentric SeCoIA study protocol

Natalia Target et al. BMC Nephrol. .

Abstract

Background: Home haemodialysis (HHD), has shown improved clinical outcomes, as well as a better quality of life, compared to conventional in-centre haemodialysis (ICHD) but still has a global low prevalence among end-stage renal disease patients. Haemodialysis (HD) patients tend to be sedentary but only few studies, mainly in North American ICHD patients, have evaluated the level of activity in HD patients.

Methods: SeCoIA is an observational, longitudinal, prospective, international, multicentric, study, conducted in metropolitan France and Belgium. The main objective of the study is to quantify the physical activity measured by the total daily number of steps, in HHD patients compared to ICHD patients. The SeCoIA study will include 80 HHD patients and 80 ICHD patients,. Secondary objectives will be to characterize the HHD population and to confirm HHD efficiency on clinical parameters, as well as quality of life (QoL), in current practice. Physical activity will be measured by a 3-axis accelerometer. Accelerometers have been shown to provide accurate information, on both physical activity and sedentary behaviour. Patients will be instructed to wear the device and complete a patient diary 7 consecutive days after inclusion and the first week of each month for 12 months. Decision to undergo HDD or ICHD is independent of the study and follow-up frequency remains at the discretion of the physician/centre. QoL and quality of sleep will be respectively assessed by the Kidney Disease Quality of Life 1.2 (KDQOL™) and the Pittsburg Sleep Quality index (PSQI) questionnaires at inclusion, 6- and 12-month visits. Patients presenting a restless leg syndrome (RLS) will also complete the International Restless Legs Syndrome rating scale (IRLS) questionnaire.

Discussion: The SeCoIA study will be the first large cohort study (160 patients) evaluating physical activity, objectively measured with a 3-axis accelerometer, in HHD versus ICHD patients. The present study will also include a comparison of QoL with a focus on RLS between HHD and ICHD. It is anticipated that HHD patients will have an improved physical activity and QoL which should encourage physicians to further promote HHD.

Trial registration: Clinical trial NCT03737578 study registered on November 9, 2018 (Retrospectively registered).

Keywords: 3-axis accelerometer; End-stage renal disease; Home haemodialysis; Physical activity; Quality of life; Restless leg syndrome.

PubMed Disclaimer

Conflict of interest statement

NT, CC and PAM have no conflict of interest. SD is an employee of Monitoring Force, a contract research organisation working for different pharmaceutical companies. MT is an employee of Physidia SAS.

Figures

Fig. 1
Fig. 1
Flow chart of the SeCoIA study
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
    1. Levin A, Tonelli M, Bonventre J, Coresh J, Donner J-A, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet Lond Engl. 2017;390:1888–1917. doi: 10.1016/S0140-6736(17)30788-2. - DOI - PubMed
    1. rapportrein2016.pdf. https://www.agence-biomedecine.fr/IMG/pdf/rapportrein2016.pdf. Accessed 22 Jan 2019.
    1. Miller BW, Himmele R, Sawin D-A, Kim J, Kossmann RJ. Choosing home hemodialysis: a critical review of patient outcomes. Blood Purif. 2018;45:224–229. doi: 10.1159/000485159. - DOI - PubMed
    1. Eneanya ND, Maddux DW, Reviriego-Mendoza MM, Larkin JW, Usvyat LA, van der Sande FM, et al. Longitudinal patterns of health-related quality of life and dialysis modality: a national cohort study. BMC Nephrol. 2019;20:7. doi: 10.1186/s12882-018-1198-5. - DOI - PMC - PubMed

Associated data